StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

BioCorRx's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.36M. For fiscal 2025 it was -$2.30M. The highest annual figure on record is $167.67K in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.30M–
FY2024Dec 31, 2024-$1.10M–
FY2023Dec 31, 2023-$1.85M–
FY2022Dec 31, 2022-$2.04M–
FY2021Dec 31, 2021-$3.54M–
FY2020Dec 31, 2020-$2.15M–
FY2019Dec 31, 2019-$2.94M–
FY2018Dec 31, 2018-$1.83M–
FY2017Dec 31, 2017-$2.54M–
FY2016Dec 31, 2016-$2.00M-4277.7%
FY2015Dec 31, 2015$47.86K-71.5%
FY2014Dec 31, 2014$167.67K+62.1%
FY2013Dec 31, 2013$103.46K–
FY2012Dec 31, 2012-$927.76K–
FY2011Dec 31, 2011-$128.39K–
FY2010Dec 31, 2010-$114.34K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$440.29K–
Q1 FY2026Mar 31, 2026-$432.97K–
Q4 FY2025Dec 31, 2025-$847.72K–
Q3 FY2025Sep 30, 2025-$634.45K–
Q2 FY2025Jun 30, 2025-$126.50K–
Q1 FY2025Mar 31, 2025-$689.62K–
Q4 FY2024Dec 31, 2024-$247.17K–
Q3 FY2024Sep 30, 2024-$357.54K–
Q2 FY2024Jun 30, 2024-$151.87K–
Q1 FY2024Mar 31, 2024-$339.67K–
Q4 FY2023Dec 31, 2023-$533.84K–
Q3 FY2023Sep 30, 2023-$350.55K–
Q2 FY2023Jun 30, 2023-$571.54K–
Q1 FY2023Mar 31, 2023-$397.36K–
Q1 FY2022Mar 31, 2022-$872.67K–
Q2 FY2021Sep 30, 2021-$1.96M–
Q1 FY2021Mar 31, 2021-$930.09K–
Q4 FY2020Dec 31, 2020-$341.33K–
Q3 FY2020Sep 30, 2020-$595.78K–
Q2 FY2020Jun 30, 2020-$539.76K–
Q1 FY2020Mar 31, 2020-$675.01K–
Q4 FY2019Dec 31, 2019-$889.16K–
Q3 FY2019Sep 30, 2019-$823.52K–
Q2 FY2019Jun 30, 2019-$901.38K–
Q1 FY2019Mar 31, 2019-$323.07K–
Q4 FY2018Dec 31, 2018-$439.42K–
Q3 FY2018Sep 30, 2018-$431.44K–
Q2 FY2018Jun 30, 2018-$545.23K–
Q1 FY2018Mar 31, 2018-$409.54K–
Q4 FY2017Dec 31, 2017-$319.23K–
Q3 FY2017Sep 30, 2017-$561.53K–
Q2 FY2017Jun 30, 2017-$822.43K–
Q1 FY2017Mar 31, 2017-$837.21K–
Q4 FY2016Dec 31, 2016-$380.80K-168.9%
Q3 FY2016Sep 30, 2016-$607.81K–
Q2 FY2016Jun 30, 2016-$734.73K–
Q1 FY2016Mar 31, 2016-$276.06K–
Q4 FY2015Dec 31, 2015$552.39K–

More BioCorRx figures

See a number that looks wrong?